Announcements Trials
Browse Landscape

Phase

Phase 3 10Phase 2 6Phase 1/2 4Phase 1 3Phase EARLY_PHASE1 2Phase 4 2Phase 2/3 2Phase NA 1

Status

Withdrawn 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Pancreatic Adenocarcinoma 1Malignant Neoplasm in the Head and Neck 1Lung Metastases 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Ethiodized Oil × Clear all
NCT04200417 2025-05-16

Chemoembolization for Lung Tumors

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
10 enrolled
Thoracic

Lung Metastases

NCT05490381 2023-12-12

Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes

University of Washington

Phase 1 Withdrawn
Head & NeckOther neoplasm

Malignant Neoplasm in the Head and Neck

NCT03865563 2020-01-27

Selective Transvenous Chemoembolization of Primary Pancreatic Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Withdrawn
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡